Interested in learning what's next for the gaming industry? Join gaming executives to discuss emerging parts of the industry this October at GamesBeat Summit Next. Learn more.
U.K.-based Oxford VR hopes to lead the way in automated VR therapy in the future, and it just raised £10 million ($13.05 million) to help achieve that goal.
The company, which span out of Oxford University’s Department of Psychiatry in 2017, raised the money in a Series A round of funding led by Optum Ventures. According to a press release, the new funds will “enable Oxford VR to accelerate US expansion of its evidence-based and scalable automated VR therapy solution and to continue to expand its treatment pipeline.”
Oxford VR is looking to turn many of the proposed health benefits of VR into a reality in the coming years. The company started out with a clinical trial, testing VR’s capability to treat a fear of heights. Since those that trial, it’s expanded its offering to tackle areas like OCD and social anxiety, too.
The platform offers automated treatment aligned with clinical standards and protocol, creating simulated events that can trigger these issues and help sufferers confront them in a safe, controlled environment. You can see an example of the company’s work tackling a fear of heights in a patient below.
This story originally appeared on Uploadvr.com. Copyright 2020
GamesBeat's creed when covering the game industry is "where passion meets business." What does this mean? We want to tell you how the news matters to you -- not just as a decision-maker at a game studio, but also as a fan of games. Whether you read our articles, listen to our podcasts, or watch our videos, GamesBeat will help you learn about the industry and enjoy engaging with it. Learn more about membership.